Precision BioSciences Inc. (DTIL): A Brand-New Prospect for Investors – Invest Chronicle

Precision BioSciences Inc. (DTIL): A Brand-New Prospect for Investors

Let’s start up with the current stock price of Precision BioSciences Inc. (DTIL), which is $1.52 to be very precise. The Stock rose vividly during the last session to $1.70 after opening rate of $1.63 while the lowest price it went was recorded $1.49 before closing at $1.65.Recently in News on May 12, 2022, Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4). Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that, on May 6, 2022, the Compensation Committee of Precision’s Board of Directors approved the grant of inducement awards to new employees under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (“Inducement Award Plan”). The inducement awards consist of options to purchase (“stock option”) an aggregate of 401,905 shares of Precision’s common stock, par value $0.000005 (the “Common Stock”), which stock options were granted among four employees who commenced employment on March 14, 2022. Each of the stock options were granted under Nasdaq Listing Rule 5635(c)(4) as an inducement for the employees to commence service with Precision. You can read further details here

Precision BioSciences Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.8500 on 01/04/22, with the lowest value was $1.4900 for the same time period, recorded on 05/12/22.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Precision BioSciences Inc. (DTIL) full year performance was -83.60%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Precision BioSciences Inc. shares are logging -89.43% during the 52-week period from high price, and -7.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.64 and $14.38.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 877045 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Precision BioSciences Inc. (DTIL) recorded performance in the market was -79.46%, having the revenues showcasing -68.53% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 92.29M, as it employees total of 198 workers.

Precision BioSciences Inc. (DTIL) in the eye of market guru’s

During the last month, 6 analysts gave the Precision BioSciences Inc. a BUY rating, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 4.2189, with a change in the price was noted -6.94. In a similar fashion, Precision BioSciences Inc. posted a movement of -82.03% for the period of last 100 days, recording 637,562 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DTIL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.03.

Precision BioSciences Inc. (DTIL): Stocks Technical analysis and Trends

Raw Stochastic average of Precision BioSciences Inc. in the period of last 50 days is set at 1.02%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 2.24%. In the last 20 days, the company’s Stochastic %K was 4.58% and its Stochastic %D was recorded 5.19%.

If we look into the earlier routines of Precision BioSciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -79.46%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -85.14%, alongside a downfall of -83.60% for the period of the last 12 months. The shares increased approximately by -21.24% in the 7-day charts and went up by -44.93% in the period of the last 30 days. Common stock shares were lifted by -68.53% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts